Substance Abuse Pre-Treatment Screening Study

• Status: Recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Amphetamine; Dextroamphetamine; Modafinil; Naltrexone

Criteria

Inclusion Criteria:

• Willing and able to participate in 3- to 6-month treatment program.

• At least 18 years of age.

• Seeking treatment for substances of abuse including (cocaine, opiates, and alcohol).

• Generally physically healthy.

Exclusion Criteria:

• Pregnant or breastfeeding.

• Mandated by the courts/parole officers to attend treatment.

• Not seeking treatment for substances of abuse.

• Plans to move from the Houston area within the 3- to 6-month treatment period.

• Seeking treatment for a substance for which the Treatment Research Clinic (TRC) has no current trial.